한국인에서 Framingham 관상동맥 위험 점수와 C-반응성 단백의 연관성

키워드

참고문헌 (24)

1. McGovern PG, "Recent trends in acute coronary heart disease: mortality, morbidity, medical care, and risk factors", N Engl J Med, 334, pp.884~890 (1996)
2. Wilson PW, "Prediction of coronary heart disease using risk factor categories", Circulation, 97, pp.1837~1847 (1998)
3. Taylor AJ, "A comparison of the Framingham risk index, coronary artery calcification, and culprit plaque morphology in sudden cardiac death", Circulation, 101, pp.1243~1248 (2000)
4. Cobb FR, "Assessing risk for coronary heart disease: beyond Framingham", Am Heart J, 146, pp.572~580 (2003)
5. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, "Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Ⅲ)", JAMA, 285, pp.2486~2497 (2001)
6. Pearson TA, "New tools for coronary risk assessment: what are their advantages and limitations?", Circulation, 105, pp.886~892 (2002)
7. Danesh J, "Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses", BMJ, 321, pp.199~204 (2000)
8. Ridker PM, "High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease", Circulation, 103, pp.1813~1818 (2001)
9. Wood D, "Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and Other Societies on Coronary Prevention", Atherosclerosis, 140, pp.199~270 (1998)
10. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetid Association, "Joint British recommendations on prevention of coronary heart disease in clinical practice", Heart, 80(Suppl 2), pp.1~29 (1998)
11. Jialal I, "Inflammation, and atherosclerosis: the value of the high sensitivity C-reactive protein assay as a marker", Am J Clin Pathol, 116(Suppl), pp.108~115 (2001)
12. Ledue TB, "Preanalytic and analytic sources of variations in C-reactive protein measurement: implications for cardiovascular disease risk assessment", Clin Chem, 49, pp.1258~1271 (2003)
13. Tracy RP, "Inflammation markers and coronary heart disease", Curr Opin Lipidol, 10, pp.435~441 (1999)
14. Pearson TA, "Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association", Circulation, 107, pp.499~511 (2003)
15. Ridker PM, "C-reactive protein and other markers of inflammation in the prediction of coronary artery disease in women", N Engl J Med, 342, pp.836~843 (2000)
16. Ridker PM, "Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events", N Engl J Med, 347, pp.1557~1565 (2002)
17. Rifai N, "High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease", Clin Chem, 47, pp.403~411 (2001)
18. Ridker PM, "Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events", N Engl J Med, 344, pp.1959~1965 (2001)
19. Ridker PM, "Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men", N Engl J Med, 336, pp.973~979 (1997)
20. Ridker PM, "Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels", Circulation, 98, pp.839~844 (1998)
21. Ridker PM, "C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction", Circulation, 97, pp.2007~2111 (1998)
22. Ballantyne CM, "Lipoprotein- associated phospholipase A2, high-sensitivity C- reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities(ARIC) Study", Circulation, 109, pp.837~842 (2004)
23. van der Meer IM, "The value of C-reactive protein in cardiovascular risk prediction", Arch Intern Med, 163, pp.1323~1328 (2003)
24. Albert MA, "Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score", Circulation, 108, pp.161~165 (2003)

관련 논문AI추천